> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 1st Office of Surveillance and Epidemiology Annual Report
- URL: https://www.fdaweb.com/1st-office-of-surveillance-and-epidemiology-annual-report/
- Published: 2021-05-12T12:00:00.000Z
- Updated: 2026-09-14T16:58:42.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5149299

The CDER Office of Surveillance and Epidemiology (OSE) 2020 annual report covers activities in the four core functions assigned to OSE — pharmacovigilance, pharmacoepidemiology, medication error prevention, and risk management. The [report](https://lnks.gd/l/eyJhbGciOiJIUzI1NiJ9.eyJidWxsZXRpbl9saW5rX2lkIjoxMDEsInVyaSI6ImJwMjpjbGljayIsImJ1bGxldGluX2lkIjoiMjAyMTA1MTEuNDAyOTgwOTEiLCJ1cmwiOiJodHRwczovL3d3dy5mZGEuZ292L21lZGlhLzE0ODQ3MS9kb3dubG9hZD91dG1fbWVkaXVtPWVtYWlsJnV0bV9zb3VyY2U9Z292ZGVsaXZlcnkifQ.swX5jHWXjlWdkkl3sJet3zTGGcNHV6uAoHqpdsd8LgY/s/1255720147/br/106212575475-l?ref=fdaweb.com) notes the Covid-19 pandemic poses particular challenges to OSE and it is using its full array of tools to ensure the safety of products for Covid-19 and to monitor their performance.

Looking ahead, the document says OSE will “continue to modernize our programs in pharmacovigilance, pharmacoepidemiology, medication error prevention and analysis, and risk management, with a sustained focus on our many Covid-19 activities. Our strategic planning will focus on enhancing drug safety surveillance activities to inform emerging safety concerns.”